Regulatory Advocacy

The AAO-HNS has a long history of working closely with regulatory agencies (e.g., Centers for Medicare & Medicaid Services, U.S. Food and Drug Administration) to maintain our visibility and credibility with national representatives regarding federal regulatory issues.

We believe that advocacy is the key to defining the future of otolaryngology. Federal regulatory advocacy is a top priority of the AAO-HNS.

Academy Submits Comments on Episode Groups to CMS
In preparation for the transition to the Merit-based Incentive Payment System (MIPS) and Alternative Payment Models (APMS), the Academy submitted comments to CMS on the development of episode groups. CMS will use care episode groups, patient condition groups and related classification codes to help determine payment rates starting in 2019.

Read the letter.

Academy Submits Comments on CMS Quality Measure Development Plan
The Academy submitted comments to the CMS in response to the CMS Quality Measure Development Plan: Supporting the Transition to the MIPS and APMs (DRAFT). The comments address CMS' strategic vision and approach to the implementation of many critical components of MIPS and APMs.

Read the comments.

Academy Comments on 2016 Medicare Physician Fee Schedule
The Academy submitted comments to the Centers for Medicare & Medicaid Services (CMS) on the 2016 Medicare Physician Fee Schedule final rule. The comments address several specific payment policy issues affecting otolaryngology including: practice expense changes; Global Surgical Package valuation; Physician Quality Reporting System and Qualified Clinical Data Registry requirements; Physician Compare; and Value Based Payment Modifier program.

Read the comments.